A diagnostic test series analyzing 136 genes for cancer-specific detection and classification. This panel supports tumor profiling and prognostic assessment across multiple cancer types.
Manufactured by
China
HaploX Biotechnology specializes in tumor liquid biopsy and genetic big data technologies. The company operates CAP/CLIA/EMQN/NCCL certified medical laboratories equipped with advanced gene sequencing platforms. Services cover tumor management, hereditary disease screening, and infectious disease detection, serving hundreds of hospitals and research institutions across China with international operations in Hong Kong, Singapore, Japan, Europe, and North America.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
shanghai rendu biotechnology co.,ltd.
China · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 4 relevant products
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 4 relevant products
Axbio (shenzhen) Co.,LTD
China · 2 relevant products
Medicover Genetics Ltd
Cyprus · 2 relevant products
Xi'an Tianlong Science And Technology Co., Ltd
China · 1 relevant product
Genes 2Me Private Ltd
India · 3 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
Biopsense Oy
Finland · 1 relevant product
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 103 closest product alternatives
shanghai rendu biotechnology co.,ltd. · China
A series of RNA-based diagnostic tests designed for early cancer screening and detection. These tests support the identification of cancer biomarkers for early intervention and patient management.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China
Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Comprehensive genetic screening kit for lung cancer biomarkers and mutations. Enables early detection and treatment planning for pulmonary malignancies.
Axbio (shenzhen) Co.,LTD · China
Molecular diagnostic kit for cancer genomics profiling and tumor mutation analysis. Enables detection of somatic mutations relevant to oncology and cancer treatment planning.
Medicover Genetics Ltd · Cyprus
Genetic testing for cancer predisposition and somatic cancer variants to identify individuals at risk or with diagnosed malignancies. Includes comprehensive sequencing with clinical validation and genetic counselling.
Xi'an Tianlong Science And Technology Co., Ltd · China
Molecular diagnostic kit for detecting genetic mutations and biomarkers associated with cancer. Supports precision oncology testing for treatment selection and monitoring.
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Nucleic acid detection kit for screening breast cancer-related genetic markers. Enables risk stratification for breast cancer predisposition assessment.
GENETRON HEALTH (BEIJING) CO., LTD · China
A diagnostic kit based on GENETRON's proprietary 'one-step method' technology enabling completion of library construction in 1.5 to 3 hours (China patent ZL 201710218529.4). It detects EGFR, KRAS, BRAF, HER2, and PIK3CA gene mutations in DNA and ALK and ROS1 gene fusions in RNA from FFPE tissue samples of non-small cell lung cancer patients, as well as MET gene 14 exon skipping mutations.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Molecular diagnostic kit for detecting colorectal cancer-associated genetic alterations. Provides genetic risk assessment for colorectal malignancy.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
91 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products